This bundle combines three mitochondria-focused research compounds — NAD+, MOTS-c, and SS-31 — each studied for a different aspect of cellular energy metabolism and oxidative stress. See each compound's own page for its individual research summary.
What's in this bundle
Combines NAD+, MOTS-C, and SS-31 — three mitochondria/metabolism-focused compounds with very different evidence tiers (SS-31/elamipretide has real Phase 2/3 human trials; MOTS-C's only human data is for an analog, not the native peptide; direct IV NAD+ has a specific worse-tolerability finding vs. its precursor). No trial has tested this specific combination.
Why are NAD+, MOTS-c, and SS-31 bundled together?+
All three are studied in mitochondrial-health and cellular-energy research, despite acting through different mechanisms, so a combined kit is offered for convenience.
Can I read about each compound individually?+
Is this bundle FDA-approved?+
No. None of the individual compounds in this bundle are FDA-approved drug products; all are sold for research use only.
Looking for something specific, or placing a wholesale order? Send us a DM or email.